— Know what they know.
Not Investment Advice

QTRX NASDAQ

Quanterix Corporation
1W: +11.3% 1M: +39.5% 3M: -15.2% YTD: -43.4% 1Y: -34.3% 3Y: -86.7% 5Y: -93.1%
$3.64
+0.23 (+6.74%)
 
Weekly Expected Move ±10.4%
$3 $3 $4 $4 $4
NASDAQ · Healthcare · Medical - Devices · Tech Score Buy · Power 59 · $171.5M mcap · 38M float · 2.33% daily turnover · Short 52% of daily vol

Supply Chain Overview

8 relationships
8
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2024-12-17
Earliest Filing
2025-08-04
Latest Filing
target: 6 partner: 2

Counterparties (Filed by QTRX)

8 relationships

Companies named in QTRX's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Kent Lake PR LLC — partner Partner in Cooperation Agreement for board director selection 2025-08-04 View
Kent Lake Partners LP — partner General partner of Kent Lake PR LLC in Cooperation Agreement 2025-08-04 View
Akoya Biosciences, Inc. — target Target company acquired by Quanterix Corporation in a merger transaction. 2025-07-08 View
Akoya Biosciences, Inc. AKYA target Target company in the merger agreement with Quanterix Corporation. 2025-04-29 View
Akoya Biosciences, Inc. AKYA target Target company in proposed merger with Quanterix; issuer of convertible notes in private placement. 2025-04-04 View
Akoya Biosciences, Inc. AKYA target Target company in the merger agreement with Quanterix Corporation. 2025-01-10 View
Emission Inc. — target Acquired by Quanterix Corporation for $10 million upfront plus potential earnouts. 2025-01-08 View
Emission Inc. — target Acquired by Quanterix Corporation for $10 million upfront with potential earnouts. 2024-12-17 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-10 Earnings Release; Regulation FD; Exhibits View
2026-06-10 Shareholder Vote View
2026-06-09 Officer/Director Change; Regulation FD; Exhibits View
2026-05-26 Officer/Director Change; Exhibits View
2026-05-12 Officer/Director Change; Regulation FD; Exhibits View
2026-05-06 Earnings Release; Regulation FD; Exhibits View
2026-03-02 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2026-01-08 Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic View
2025-11-20 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
2025-11-10 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-10-02 Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits View
2025-09-24 Submission of Matters to a Vote of Security Holders; Regulation FD Disclosure; Financial Statements View
2025-09-23 Financial Statements and Exhibits View
2025-08-07 Results of Operations and Financial Condition; Amendments to Articles of Incorporation or Bylaws; Re View
2025-08-04 Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit Agreement View
2025-07-24 Costs Associated with Exit or Disposal Activities; Financial Statements and Exhibits View
2025-07-18 Costs Associated with Exit or Disposal Activities View
2025-07-08 Completion of Acquisition or Disposition of Assets; Departure/Election of Directors; Appointment of Acquisition View
2025-07-01 Shareholder Nominations; Other Events; Financial Statements and Exhibits View
2025-05-14 Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms